Analysis of mutational burden and adaptive immune response in desmoplastic melanomas treated with PD-1/L1 inhibitors.
Authors:
- Siwen Hu-LieskovanSHSiwen Hu-Lieskovan
- Zeynep ErogluZEZeynep Eroglu
- Jesse Meir ZaretskyJZJesse Meir Zaretsky
- Dae Won KimDKDae Won Kim
- Alain Patrick AlgaziAAAlain Patrick Algazi
- Douglas Buckner JohnsonDJDouglas Buckner Johnson
- Ben KongBKBen Kong
- Rodrigo MunhozRMRodrigo Munhoz
- Suthee RapisuwonSRSuthee Rapisuwon
- Bartosz ChmielowskiBCBartosz Chmielowski
- Jeffrey Alan SosmanJSJeffrey Alan Sosman
- 20 May 2017
- journal article
- abstracts
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 35 (15_suppl) , 9558